2019-21321. Importer of Controlled Substances Registration  

  • Start Preamble

    ACTION:

    Notice of registration.

    SUMMARY:

    The registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of schedule I and II controlled substances.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The companies listed below applied to be registered as an importers of various basic classes of schedule I and II controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for a hearing were submitted for these notices.

    CompaniesFR docketPublished
    Restek Corporation84 FR 35691July 24, 2019.
    AMRI Rensselaer, Inc84 FR 35692July 24, 2019.
    Alcami Carolinas Corporation84 FR 36941July 30, 2019.
    Cambrex Charles City84 FR 36945July 30, 2019.
    Chattem Chemicals, Inc83 FR 39129August 8, 2019.

    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable various basic classes of schedule I and II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each of the company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.

    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I and II controlled substances to the above listed companies.

    Start Signature

    Dated: September 23, 2019

    Thomas W. Prevoznik,

    Acting Assistant Administrator, Deputy Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2019-21321 Filed 9-30-19; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
10/01/2019
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of registration.
Document Number:
2019-21321
Pages:
52136-52136 (1 pages)
Docket Numbers:
Docket No. DEA-392
PDF File:
2019-21321.Pdf